Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Unavailable
    Pharmaceutical Applications of Dendrimers
    Unavailable
    Pharmaceutical Applications of Dendrimers
    Unavailable
    Pharmaceutical Applications of Dendrimers
    Ebook845 pages7 hours

    Pharmaceutical Applications of Dendrimers

    ()

    Currently unavailable

    Currently unavailable

    About this ebook

    Pharmaceutical Applications of Dendrimers explores the applications of dendrimers in the solubilization of hydrophobic active ingredients, drug delivery, gene delivery, imaging, diagnosis and photodynamic therapy. The book discusses the diagnostic applications of dendrimers, including their use as MRI contrast agents and in the imaging of diseased areas. In addition, the anti-inflammatory, antimicrobial and antiviral properties of PPI and PAMAM are also covered, along with a discussion on photosensitizers, such as rose Bengal and protoporphyrin IX that have been delivered using PAMAM and PPI dendrimers for the treatment of cancer.

    This book is an important research reference for those who want to learn more about the development of dendrimer-based solutions for drug delivery.

    • Explores the role of dendrimers in the design of dendritic nanoplatforms for targeted drug and gene delivery systems
    • Discusses the potential of dendrimers in preformulation and formulation development
    • Addresses both clinical and regulatory challenges in the development of dendrimer-based formulations
    LanguageEnglish
    PublisherElsevier Science
    Release dateNov 15, 2019
    ISBN9780128145289
    Unavailable
    Pharmaceutical Applications of Dendrimers

    Related to Pharmaceutical Applications of Dendrimers

    Titles in the series (97)

    View More
    View More

    Related ebooks

    Materials Science For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      Open Source Tool Picks Best Chemo Drug 80% Of The Time

      Dec 4, 2018

      A new machine learning tool could help find the chemotherapy drug most likely to attack cancer in individual patients. The tool, which analyzes RNA expression tied to information about patient outcomes with specific drugs, predicted the chemotherapy

      3 min read

    • Article

      Opinion: Synthetic Control Arms Can Save Time And Money In Clinical Trials

      Feb 5, 2019

      Synthetic control arms aren't the solution to all of the challenges facing randomized trials, but they represent a great way for drug development companies to start using real-world evidence.

      4 min read

    • Article

      Opinion: From Bench To Bedside, Biologics Require Excellence At Every Stage

      Feb 13, 2020

      Quality and trust go together. As an industry, biologic manufacturers must deliver on quality. Public trust of sophisticated biological products will follow.

      3 min read

    • Article

      Indian Pharma's Big Leap

      Apr 30, 2018

      Indian Pharma's Big Leap
      6 min read

    • Article

      Opinion: Manufacturing: The Next Breakthrough In Gene Therapy

      Dec 18, 2019

      As the race heats up to bring gene therapy to market, breakthroughs in manufacturing are often the key — or break down the barrier — to delivering these therapies to…

      3 min read

    • Article

      Opinion: Enough With The Me-too Drugs. New Treatments Should Be Worthy Of The People Who Invest Their Lives In Clinical Trials

      Sep 4, 2019

      Drug developers should should treat patients who volunteer for clinical trials the way they would treat their mothers or husbands or best friends — but often don't.

      3 min read

    • Article

      Failing The Test

      May 2, 2020

      Failing The Test
      8 min read

    • Article

      Dr. Satya Vadlamani spearheading The New Age Of The India Pharma Industry

      Dec 23, 2023

      Dr. Satya Ramani Vadlamani is the Chairperson and the Managing Director of Murli Krishna Pharma Private Ltd., a young and dynamic NanoSphere Innovations company in India that provides a range of effective solutions to optimize the delivery of pharmac

      2 min read

    • Article

      Opinion: Bringing Order To The ‘Wild Frontier’ Of Microbiome Medicine

      Oct 2, 2018

      When it comes to #microbiome medicine, @US_FDA and @NIH need to create a solid, science-based regulatory framework to help realize the promise of living drugs.

      4 min read

    • Article

      Q & A

      Nov 27, 2021

      With the COVID19 pandemic exerting enormous pressure on the healthcare infrastructure, the sector finds itself under the compulsion to step up. In this interview Dr. G.V. Sampath, Chairman, Naruvi Hospitals, Vellore addresses how India can make optim

      2 min read

    • Article

      Opening The ‘Black Box,’ Google DeepMind AI System Diagnoses Eye Diseases And Shows Its Work

      Aug 13, 2018

      Experts said the level of accuracy is impressive, but the bigger breakthrough is the DeepMind system’s solution to the so-called “black box” problem of artificial intelligence.

      5 min read

    • Article

      This Method Cuts Toxic Side Effects of Nanodrug Chemo

      Dec 5, 2017

      Administering an FDA-approved nutrition source called Intralipid before nanodrug chemotherapy can reduce the amount of the toxic drugs that settle in the spleen, liver, and kidneys, researchers report. “This methodology could have a major impact in t

      1 min read

    • Article

      Opinion: Companies Must Responsibly Manufacture The Antimicrobials Society Needs

      Jan 30, 2020

      Providing access to antibiotics and other antimicrobials while reducing resistance to these medicines presents a dual manufacturing challenge: ensuring a cost-effective supply while minimizing their emission into the environment.

      4 min read

    • Article

      Opinion: The FDA Needs To Set Standards For Using Artificial Intelligence In Drug Development

      Nov 7, 2019

      Poorly constructed AI algorithms for drug discovery and testing have the potential to cause harm. The FDA should play an important role in ensuring that AI-based drug development tools meet…

      3 min read

    • Article

      Opinion: FDA Is Smashing The Status Quo For Regulatory Science

      Oct 14, 2019

      The FDA can enable innovation by being a partner in advancing new approaches to drug development and regulatory science. Its recent reorganization signals a revolutionary shift in regulatory velocity.

      5 min read

    • Article

      Opinion: Real-world Data Can Help Make Better Drugs And Do It Faster

      May 2, 2018

      Relying solely on clinical trials to demonstrate the safety and effectiveness of new drugs can be risky. Real-world data can help.

      4 min read

    • Article

      Dr. William Levine

      Jan 3, 2020

      Dr. William Levine
      5 min read

    • Article

      The Elusive Miracle Drug

      Jun 27, 2020

      The Elusive Miracle Drug
      4 min read

    Related categories

    Reviews for Pharmaceutical Applications of Dendrimers

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words